ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.001,60
0,54%
S&P 500
5.127,79
1,26%
Dow Jones
38.675,68
1,18%
Euro vs US Dollar
1,07725
0,00%
Bitcoin
63.433,65
-0,72%
Registration Strip Icon for discussion Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. Creative Medical Technology Holdings Inc (CELZ)

  7. Creative Medical Technology Holdings Inc (CELZ) News

CELZ

Creative Medical Technol... (CELZ)

Creative Medical Technology Holdings Inc
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:CELZ
DatumZeitQuelleÜberschriftSymbolFirma
27/03/202414h00Business WireCreative Medical Technology Holdings Provides Corporate UpdateNASDAQ:CELZCreative Medical Technology Holdings Inc
07/03/202415h15Business WireCreative Medical Technology Holdings Inc. Announces FDA Authorization for Groundbreaking Type 1 Diabetes Prevention Therapy Under Expanded AccessNASDAQ:CELZCreative Medical Technology Holdings Inc
06/03/202422h10AllPennyStocks.comBiotech Finds Mid-Week Success Following FDA AnnouncementNASDAQ:CELZCreative Medical Technology Holdings Inc
06/03/202413h00Business WireCreative Medical Technology Holdings, Inc. Receives FDA Orphan Drug Designation for CELZ-101 in Key Transplantation TherapyNASDAQ:CELZCreative Medical Technology Holdings Inc
20/12/202322h05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CELZCreative Medical Technology Holdings Inc
15/11/202314h00PR Newswire (US)Creative Medical Technology Holdings Provides Corporate UpdateNASDAQ:CELZCreative Medical Technology Holdings Inc
03/11/202321h05Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:CELZCreative Medical Technology Holdings Inc
10/10/202314h00PR Newswire (US)Creative Medical Technology Holdings Announces IRB Approval for FDA Cleared Phase 1/2 Clinical Trial of StemSpine® using AlloStem™ ("CELZ-201-DDT") Novel Cell Therapy to Treat Chronic Lower Back PainNASDAQ:CELZCreative Medical Technology Holdings Inc
19/09/202314h00PR Newswire (US)Creative Medical Technology Holdings Receives FDA Clearance to Initiate a Phase 1/2 Clinical Trial of StemSpine® using AlloStem™ (CELZ-201-DDT) for the Treatment of Chronic Lower Back PainNASDAQ:CELZCreative Medical Technology Holdings Inc
11/08/202322h45Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:CELZCreative Medical Technology Holdings Inc
29/06/202323h38Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CELZCreative Medical Technology Holdings Inc
29/06/202323h37Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CELZCreative Medical Technology Holdings Inc
28/06/202315h01Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CELZCreative Medical Technology Holdings Inc
28/06/202315h00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CELZCreative Medical Technology Holdings Inc
28/06/202314h00PR Newswire (US)Creative Medical Technology Holdings Regains Compliance With Nasdaq Listing RequirementsNASDAQ:CELZCreative Medical Technology Holdings Inc
12/06/202314h01PR Newswire (US)Creative Medical Technology Announces $2 Million Share Repurchase ProgramNASDAQ:CELZCreative Medical Technology Holdings Inc
12/06/202314h00PR Newswire (US)Creative Medical Technology Holdings Provides Corporate UpdateNASDAQ:CELZCreative Medical Technology Holdings Inc
09/06/202322h16Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CELZCreative Medical Technology Holdings Inc
09/06/202318h30PR Newswire (US)Creative Medical Technology Holdings Announces Reverse Stock SplitNASDAQ:CELZCreative Medical Technology Holdings Inc
31/05/202314h00PR Newswire (US)Creative Medical Technology Holdings Announces Successful Completion of the First Phase of its Program with Greenstone Biosciences, Inc. to Develop Next Generation iPSC Pipeline for ImmCelz® Immunotherapy PlatformNASDAQ:CELZCreative Medical Technology Holdings Inc
22/05/202314h30PR Newswire (US)Creative Medical Technology Holdings Announces Next Milestone Achievements in ImmCelz® Platform DevelopmentNASDAQ:CELZCreative Medical Technology Holdings Inc
18/05/202314h00PR Newswire (US)Creative Medical Technology Holdings Announces Positive Top-Line Study Results for Chronic Lower Back Pain Utilizing its StemSpine® Procedure Using AlloStem™ Allogenic Cell LineNASDAQ:CELZCreative Medical Technology Holdings Inc
12/05/202322h32Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:CELZCreative Medical Technology Holdings Inc
01/05/202322h47Edgar (US Regulatory)Amended Annual Report (10-k/a)NASDAQ:CELZCreative Medical Technology Holdings Inc
12/04/202321h30AllPennyStocks.comBiotech Up Massively On Follow-Up DataNASDAQ:CELZCreative Medical Technology Holdings Inc
12/04/202314h00PR Newswire (US)Creative Medical Technology Announces Positive Top-Line Results for Type 2 Diabetes StudyNASDAQ:CELZCreative Medical Technology Holdings Inc
04/04/202314h00PR Newswire (US)Creative Medical Technology Holdings Announces Filing of 2022 Form 10-K and Provides Business UpdateNASDAQ:CELZCreative Medical Technology Holdings Inc
31/03/202322h47Edgar (US Regulatory)Annual Report (10-k)NASDAQ:CELZCreative Medical Technology Holdings Inc
23/03/202313h00PR Newswire (US)Creative Medical Technology Files Orphan Drug Designation Application with the U.S. FDA Using the ImmCelz® Platform for the Treatment of Brittle Type 1 DiabetesNASDAQ:CELZCreative Medical Technology Holdings Inc
21/03/202313h00PR Newswire (US)Creative Medical Technology Holdings Announces Key Milestones Regarding ImmCelz® Platform DevelopmentNASDAQ:CELZCreative Medical Technology Holdings Inc
 Showing the most relevant articles for your search:NASDAQ:CELZ

Kürzlich von Ihnen besucht

COIN
ETHUSD
Ethereum
NYSE
MRK
Merck
NASDAQ
MSFT
Microsoft
TG
RHM
Rheinmetall
AMEX
XLE
Energy Select Sector SPDR
TG
MBG
MercedesBenz
TG
D7G
Nel ASA
DBI
DAX
DAX
NYSE
NKE
Nike
NASDAQ
NVDA
NVIDIA
NASDAQ
TSLA
Tesla
FX
EURUSD
Euro vs US Dollar
USOTC
BASFY
BASF (QX)
USOTC
BNPQY
BNP Paribas (QX)
TG
CBK
Commerzbank
USOTC
RHHBY
Roche (QX)
Delayed Upgrade Clock
ADVFN Logo

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten